Nevro Corp. Completes Enrollment of US Randomized Pivotal Trial of Novel … – MarketWatch (press release)

by admin on March 12, 2013

Nevro Corp. Completes Enrollment of US Randomized Pivotal Trial of Novel
MarketWatch (press release)
MENLO PARK, Calif., Mar 12, 2013 (BUSINESS WIRE) — Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, today announced completion of enrollment in the SENZA-RCT U.S.

View full post on chronic pain – Google News

Previous post:

Next post: